Ehab Y. Hanna, M.D., F.A.C.S.
Department of Head and Neck Surgery, Division of Surgery
About Dr. Hanna
Ehab Hanna, M.D., FACS, is an internationally recognized head and neck surgeon and expert in the treatment of patients with skull base tumors and head and neck cancer. He is Professor and Vice Chair of the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center in Houston, Texas. After earning his medical degree, he completed a surgery internship at Vanderbilt University, and residency in Otolaryngology-Head and Neck Surgery at The Cleveland Clinic in Cleveland, Ohio. He received advanced fellowship training in skull base surgery and head and neck surgical oncology at the University of Pittsburgh Medical Center. He joined the MD Anderson faculty in 2004 with a joint appointment at Baylor College of Medicine. He is the medical director of the Multidisciplinary Head and Neck Center and co-director of the Skull Base Tumor program at MD Anderson. Dr. Hanna was recently elected President of the North American Skull Base Society (NASBS) which was founded in 1989, and is a professional medical society that facilitates communication worldwide between individuals pursuing clinical and research excellence in skull base surgery. Dr. Hanna is leading the development of minimally invasive and robotic applications in skull base surgery. He has consistently been named one of America's Top Doctors by the Castle Connolly Guide. In addition to patient care, Dr. Hanna is actively engaged in clinical and translational research with emphasis on skull base tumors. He is the Editor-in-Chief of the journal of Head & Neck, which is the official journal of the International Federation of Head and Neck Societies. He also co-edited a text book on "Comprehensive Management of Skull Base Tumors".
Present Title & Affiliation
Primary Appointment
Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Adjunct Professor of Otolaryngology, Department of Otorhinolaryngology and Communicative Sciences, Head and Neck Surgery, Baylor College of Medicine, Houston, TX
Research Interests
Novel diagnostic or therapeutic strategies for tumors of the cranial base Genomic and molecular characterization of skull base tumors Robotic surgery of the skull base
Education & Training
Degree-Granting Education
1987 | Ain Shams University School of Medicine, Cairo, EGY, MS, Otolaryngology-Head and Neck Surgery |
1982 | Ain Shams University School of Medicine, Cairo, EGY, MD, Medicine |
1977 | Ain Shams University School of Science, Cairo, EGY, BS, Biology |
Postgraduate Training
1993-1994 | Fellowship, Advanced Cranial Base and Head and Neck Oncologic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA |
1990-1993 | Residency, Otolaryngology-Head and Neck Surgery, Cleveland Clinic Foundation, Cleveland, OH |
1989-1990 | Internship, General Surgery, Vanderbilt University Medical Center, Nashville, TN |
1988-1989 | Residency, Otolaryngology-Head and Neck Surgery, Cleveland Clinic Foundation, Cleveland, OH |
1985-1988 | Residency, Surgery (Otolaryngology-Head and Neck), Ain Shams University, Cairo |
1983-1984 | Clinical Internship, Surgery, Ain Shams University, Cairo |
Board Certifications
1994 | American Board of Otolaryngology |
Experience & Service
Administrative Appointments/Responsibilities
Executive Medical Director, Ambulatory Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021
Medical Director of the Head and Neck Center, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2023
Vice Chair for Clinical Affairs, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2022
Other Appointments/Responsibilities
Director, Visiting Fellowship Program for Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - Present
Member, Faculty Leadership Academy, Cohort VI, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2006
Member, Clinical Safety and Effectiveness Training, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2006
Endowed Positions
Charles and Daneen Stiefel Chair in Cancer Research, Department of Head and Neck Surgery - Research, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present
Honors & Awards
2017 | Top Doctors - Texas, Texas Monthly |
2017 | America's Most Honored Prossionals 2017 - Top 1%, American Registry |
2017 | Marquis Who's Who, Marquis Who's Who LLC |
2017 | Texas Super Doctors, Super Doctors |
2017 | Best Doctors in America, Best Doctors |
2016 | America's Top Doctors: Cancer 2016, Castle Connolly Medical LTD |
2016 | The Jack and Beverly Randall Prize for Excellence in Cancer Treatment, Jack and Beverly Randall Foundation, Inc |
2016 | America's Most Honored Professionals, American Registry |
2016 | American Head and Neck Society (AHNS) Distinguished Service Award, American Head and Neck Society |
2016 | Houston's 211 Top Doctors, Castle Connolly |
2016 | America's Best Physician, National Consumer Advisory Board |
2016 | Patients' Choice Award |
2013 | America's Top Physicians for Cancer, Showmark Media LLC |
2012 | Super Doctors, Texas Super Doctors® 2012 |
2010 | Marquis Who's Who, Marquis Who's Who LLC |
2009 | Houston Top Doctors, H Texas Magazine |
2003 | Red Sash Teaching Award, University of Arkansas for Medical Sciences |
2001 | Otolaryngology Teaching Award, University of Arkansas for Medical Sciences |
2001 | Americas Top Doctors, Castle Connolly Medical LTD |
2000 | Red Sash Teaching Award, University of Arkansas for Medical Sciences |
2000 | Honor Award, American Academy of Otolaryngology-Head and Neck Surgery |
1999 | Red Sash Teaching Award, University of Arkansas for Medical Sciences |
1998 | Otolaryngology Teaching Award, University of Arkansas for Medical Sciences |
1998 | Public Service Award, American Society for Head and Neck Surgery |
1998 | Best Doctors in America, Best Doctors, Inc |
1996 | Otolaryngology Teaching Award, University of Arkansas for Medical Sciences |
1993 | Resident Research Competition Award, First Place, Northeast Ohio Society of Otolaryngology |
1993 | George Crile Travel Fellowship Award, Cleveland Clinic Foundation |
1992 | Bruce Stewart Fellowship Award, Cleveland Clinic Foundation |
1991 | William F. Lower Award, Cleveland Clinic Foundation |
1991 | Resident Research Competition Award, Second Place, Northeast Ohio Society of Otolaryngology |
1987 | National Resident Award, Ministry of Health, Cairo, Egypt |
1982 | National Medical Student Award, Ministry of Health, Cairo, Egypt |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Mehta GU, DeMonte F, Su SY, Kupferman ME, Hanna EY, Raza SM. Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension. J Neurosurg:1-8. e-Pub 2018. PMID: 30074455.
- Raza SM, Gidley PW, Kupferman ME, Hanna EY, Su SY, DeMonte F. Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oper Neurosurg (Hagerstown) 14(6):611-619, 2018. e-Pub 2017. PMID: 28962038.
- Mays AC, Bell D, Ferrarotto R, Phan J, Roberts D, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Hanna EY, Su SY. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope 128(6):1274-1280, 2018. e-Pub 2017. PMID: 29226334.
- Reyes-Gibby CC, Wang J, Yeung SJ, Chaftari P, Yu RK, Hanna EY, Shete S. Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep 8(1):8789, 2018. e-Pub 2018. PMID: 29884837.
- Freeman JL, DeMonte F, Al-Holou W, Gidley PW, Hanna EY, Kupferman ME, Su SY, Raza SM. Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien) 160(4):731-740, 2018. e-Pub 2017. PMID: 29270681.
- Hanna EY, Abdelmeguid ASA, Roberts D, Bell AH, Weber RS, Bell D. Cellular subtype may predict survival outcomes in salivary adenoid cystic carcinoma patients-a single-institution experience. Virchows Arch 472(3):505-512, 2018. e-Pub 2017. PMID: 29063189.
- Amit M, Tam S, Abdelmeguid AS, Roberts DB, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY. Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma. Cancer 124(3):514-520, 2018. e-Pub 2017. PMID: 29044491.
- Mehta GU, Hanna EY, DeMonte F, Raza SM. Endoscopic endonasal resection of sinonasal/anterior skull base malignancy (Kadish C esthesioneuroblastoma). Acta Neurochir (Wien) 160(2):361-366, 2018. e-Pub 2017. PMID: 29277853.
- Amit M, Na'ara S, Hanna EY. Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma. Curr Oncol Rep 20(2):10, 2018. e-Pub 2018. PMID: 29492677.
- Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY. Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma. J Neurol Surg B Skull Base 78(6):512-518, 2017. e-Pub 2017. PMID: 29142805.
- Goepfert RP, Fuller CD, Gunn GB, Hanna EY, Lewin JS, Zaveri JS, Hubbard RM, Barrow MP, Hutcheson KA. Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors. Head Neck 39(11):2151-2158, 2017. e-Pub 2017. PMID: 28736965.
- MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):186, 2017. e-Pub 2017. PMID: 29169353.
- Pollard C, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck 39(10):2079-2087, 2017. e-Pub 2017. PMID: 28741749.
- Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB, MD Anderson Head and Neck Cancer Symptom Working Group. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck 39(10):2048-2056, 2017. e-Pub 2017. PMID: 28763137.
- Bengu Cobanoglu H, Hanna EY, Bell D, Esmaeli B. Desmoplastic Small Round Cell Tumor Presenting as an Ocular Mass: Unusual Localization and Remarkable Surgical Approach. Curr Oncol Rep 19(12):80, 2017. e-Pub 2017. PMID: 29043531.
- MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):150, 2017. e-Pub 2017. PMID: 28888224.
- Su SY, Bell D, Ferrarotto R, Phan J, Roberts D, Kupferman ME, Frank SJ, Fuller CD, Gunn GB, Kies MS, Glisson BS, Hanna EY. Outcomes for Olfactory Neuroblastoma Treated with Induction Chemotherapy. Head Neck 39(8):1671-1679, 2017. e-Pub 2017. PMID: 28561956.
- Hutcheson KA, Yuk M, Hubbard R, Gunn GB, Fuller CD, Lai SY, Lin H, Garden AS, Rosenthal DI, Hanna EY, Kies MS, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. Head Neck 39(8):1516-1523, 2017. e-Pub 2017. PMID: 28452175.
- Reyes-Gibby CC, Melkonian SC, Hanna EY, Yeung SJ, Lu C, Chambers MS, Banala SR, Gunn GB, Shete SS. Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck 39(6):1195-1204, 2017. e-Pub 2017. PMID: 28346771.
- López F, Triantafyllou A, Snyderman CH, Hunt JL, Suárez C, Lund VJ, Strojan P, Saba NF, Nixon IJ, Devaney KO, Alobid I, Bernal-Sprekelsen M, Hanna EY, Rinaldo A, Ferlito A. Nasal juvenile angiofibroma: Current perspectives with emphasis on management. Head Neck 39(5):1033-1045, 2017. e-Pub 2017. PMID: 28199045.
- Amit M, Tam S, Abdelmeguid AS, Roberts DB, Takahashi Y, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY. Mutation Status among Patients with Sinonasal Mucosal Melanoma and its Impact on Survival. Br J Cancer. e-Pub 2017. PMID: 28494469.
- Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK, Expert Panel on Radiation Oncology - Head and Neck Cancer. ACR appropriateness criteria(®) nasal cavity and paranasal sinus cancers. Head Neck 39(3):407-418, 2017. e-Pub 2016. PMID: 28032679.
- Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One 12(7):e0180396, 2017. e-Pub 2017. PMID: 28678827.
- López F, Devaney KO, Hanna EY, Rinaldo A, Ferlito A. Metastases to nasal cavity and paranasal sinuses. Head Neck 38(12):1847-1854, 2016. e-Pub 2016. PMID: 27218239.
- Reyes-Gibby CC, Wang J, Silvas MR, Yu RK, Hanna EY, Shete S. Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients. Sci Rep 6:34206, 2016. e-Pub 2016. PMID: 27670397.
- Esmaeli B, Yin VT, Hanna EY, Kies MS, William WN, Bell D, Frank SJ. Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma. Head Neck 38(8):1258-62, 2016. e-Pub 2016. PMID: 27027275.
- Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 6(4):241-7, 2016. e-Pub 2015. PMID: 26979544.
- Bell D, Bell AH, Bondaruk J, Hanna EY, Weber RS. Addendum to Bell et al's "In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type". Cancer 122(14):2278-9, 2016. e-Pub 2016. PMID: 27148669.
- Bell D, Bell AH, Bondaruk J, Hanna EY, Weber RS. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type. Cancer 122(10):1513-22, 2016. e-Pub 2016. PMID: 26953815.
- Tao R, Ma D, Takiar V, Frank SJ, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Rosenthal DI, Edson MA, Esmaeli B, Kupferman ME, Hanna EY, Garden AS, Phan J. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck 38 Suppl 1:E580-7, 2016. e-Pub 2015. PMID: 25782700.
- Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist H, Hunt JL, Kusafuka K, Perez-Ordoñez B, Williams MD, Takes RP, Ferlito A. Neuroendocrine Neoplasms of the Sinonasal Region. Head Neck 38 Suppl 1:E2259-66, 2016. e-Pub 2015. PMID: 26041714.
- Bhattasali O, Holliday E, Kies MS, Hanna EY, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Zhu XR, Frank SJ. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature. Head Neck 38 Suppl 1:E1472-80, 2016. e-Pub 2015. PMID: 26561041.
- Takahashi Y, Lee J, Pickering C, Bell D, Jiffar TW, Myers JN, Hanna EY, Kupferman ME. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head Neck 38 Suppl 1:E1926-34, 2016. e-Pub 2016. PMID: 26752332.
- Lee S, Spinks TE, Guzman AB, Weber RS, Hanna EY, Hessel AC, Beadle BM, Hutcheson KA, Incalcaterra J, Wood NM, Jones D, Feeley TW. Measuring value in bundled payments for head and neck cancer. J Clin Oncol 34:11, 2016.
- Ramakrishna R, Raza SM, Kupferman M, Hanna E, DeMonte F. Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach. J Neurosurg 124(1):1-7, 2016. e-Pub 2015. PMID: 26252456.
- Bell D, Hanna EY, Agaimy A, Weissferdt A. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch 467(6):649-656, 2015. e-Pub 2015. PMID: 26407663.
- Bossi P, Saba NF, Vermorken JB, Strojan P, Pala L, de Bree R, Rodrigo JP, Lopez F, Hanna EY, Haigentz M, Takes RP, Slootweg PJ, Silver CE, Rinaldo A, Ferlito A. The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treat Rev 41(10):836-43, 2015. e-Pub 2015. PMID: 26255226.
- Su YX, Roberts DB, Hanna EY, El-Naggar A, Saylam G, Frank SJ, Weber RS, Kupferman ME. Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands. Ann Surg Oncol 22(11):3701-7, 2015. e-Pub 2015. PMID: 25636455.
- Raza SM, Ramakrishna R, Weber RS, Kupferman ME, Gidley PW, Hanna EY, DeMonte F. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg 123(3):781-8, 2015. e-Pub 2015. PMID: 25909577.
- Huang AT, Tang C, Bell D, Yener M, Izquierdo L, Frank SJ, El-Naggar AK, Hanna EY, Weber RS, Kupferman ME. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol 51(6):610-5, 2015. e-Pub 2015. PMID: 25843792.
- Bell D, Ferrarotto R, Fox MD, Roberts D, Hanna EY, Weber RS, El-Naggar AK. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biol Ther 16(6):0, 2015. e-Pub 2015. PMID: 25923130.
- Bell D, Hanna EY, Miele L, Roberts D, Weber RS, El-Naggar AK. Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma. Ann Diagn Pathol 18(1):10-3, 2014. e-Pub 2013. PMID: 24238845.
- El-Sawy T, Frank SJ, Hanna E, Sniegowski M, Lai SY, Nasser QJ, Myers J, Esmaeli B. Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas. Ophthal Plast Reconstr Surg 29(6):454-7, 2013. PMID: 24195987.
- Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High symptom burden prior to radiation therapy for head and neck cancer: A patient-reported outcomes study. Head Neck 35(10):1490-8, 2013. e-Pub 2012. PMID: 23169304.
- Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg 135(12):1219-24, 2009. PMID: 20026819.
- DeMonte F, Hanna EY. Transmaxillary exploration of the intracranial portion of the maxillary nerve for malignant perineural disease. Journal of Neurosurgery 107:672-7, 2007. PMID: 17886571.
- Lupinetti A, Roberts D, Williams M, Kupferman M, Rosenthal D, DeMonte F, El-Naggar AK, Weber RS, Hanna EY. Sinonasal adenoid cystic carcinoma: MD Anderson Cancer Center experience. Cancer 110:2726-31, 2007. PMID: 17960615.
- Hanna EY, Holsinger C, DeMonte F, Kupferman M. Robotic endoscopic surgery of the skull base: A novel surgical approach. Archives of Otolaryngology-Head and Neck Surgery 133:1209-14, 2007. PMID: 18086961.
- Hanna EY. Subglottic cancer. Am J Otolaryngol 15(5):322-8, 1994. PMID: 7978035.
- Hanna E, Levine H, Timen S, Kotton B. Hypoplasia of the Maxillary Antrum: Anatomic Abnormalities, Diagnostic Difficulties and Surgical Implications. American Journal of Rhinology 7:105-110, 1993.
- Hanna E, Eliachar I, Cothren R, Ivanc T, Hughes G. Laser welding of fascial grafts and its potential application in tympanoplasty: an animal model. Otolaryngol Head Neck Surg 108:356-66, 1993. PMID: 8483607.
- Pappay F, Hanna E, Gupta M, Lavertu P, Wood B, Tan M. The Role of Squamous Carcinoma Antigen, Ferritin, and Carcino Embryonic Antigen as Serum Markers of Head and Neck Tumors. Surgery Forum 44:618-620, 1993.
Books (edited and written)
- Hanna E, DeMonte F. Comprehensive Management of Skull Base Tumors. Informa: New York, 2009.
- Myers, E, Suen JY, Myers J, Hanna E. Cancer of the Head and Neck. 4th. W.B. Saunders: New York, NY, 2003.
Grant & Contract Support
Title: | A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors |
Funding Source: | Radiation Therapy Oncology Group |
Role: | Principal Investigator |
Title: | Molecular Epidemiology of Neuropathic Pain in Head and Neck Cancer |
Funding Source: | NIH/NIDCR |
Role: | Co-Investigator |
Title: | Charles and Daneen Stiefel Chair in Cancer Research |
Funding Source: | Charles & Daneen Stiefel |
Role: | Chair |
Title: | A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors |
Funding Source: | National Clinical Trials Network (NCTN) |
Role: | Principal Investigator |
Patient Reviews
CV information above last modified August 26, 2024